Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Clinical trial NCT04975178 · RECRUITING
Trial details
- NCT number
- NCT04975178
- Sponsor
- Biofabri, S.L
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2029-02-01
- Enrollment
- 7120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.